ITA5919
ITA5919
- Catalog: ITA5919
- Gene/Protein: OPRD1
- Product Description: Immunotag™ OPRD1 Antibody
385.0000
Price in reward points: 385
Your shopping cart is empty!
Antibody Specification | |
Datasheet | |
Target Protein | OPRD1 |
Clonality | Polyclonal |
Storage/Stability | -20°C/1 year |
Application | WB,IF/ICC,ELISA |
Recommended Dilution | WB 1:500~1:1000 IF 1:100-500 ELISA(peptide) 1:20000-1:40000 |
Concentration | 1 mg/ml |
Reactive Species | Human |
Host Species | Rabbit |
Immunogen | A synthesized peptide |
Specificity | OPRD1 Antibody detects endogenous levels of total OPRD1 |
Purification | The antiserum was purified by peptide affinity chromatography. |
Form | Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt |
Gene Name | OPRD1 |
Accession No. | P41143 |
Alternate Names | D-OR-1; Delta type opioid receptor; Delta type opioid receptor DOR 1; Delta type opioid receptor DOR1; Delta-type opioid receptor; DOR 1; DOR-1; DOR1; mDOR; Nbor; Opioid receptor delta 1; OPRD 1; OPRD; OPRD_HUMAN; Oprd1; |
Description | G-protein coupled receptor that functions as receptor for endogenous enkephalins and for a subset of other opioids. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain and in opiate-mediated analgesia. Plays a role in developing analgesic tolerance to morphine. |
Cell Pathway/ Category | Primary Polyclonal Antibody |
Protein MW | 36 KD |
Usage | For Research Use Only! Not for diagnostic or therapeutic procedures. |